PDS Biotechnology Corpora... (PDSB)
NASDAQ: PDSB
· Real-Time Price · USD
1.20
0.00 (0.00%)
At close: Aug 15, 2025, 3:59 PM
1.22
1.66%
After-hours: Aug 15, 2025, 07:12 PM EDT
PDS Biotechnology Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 59.07K | 59.07K | 59.07K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 59.79K | 74.92K | 74.2K | 59.07K | 58.34K | 117.88K | 177.84K | 175.01K | 160.61K | 146.2K | 132.18K | 181.81K | 243.34K | 183.08K | 122.74K | 61.53K | n/a | n/a |
Gross Profit | -727 | -15.86K | -15.13K | -59.07K | -58.34K | -117.88K | -177.84K | -175.01K | -258.28K | -243.88K | -229.85K | -279.48K | -243.34K | -244.61K | -246.39K | -185.18K | -123.65K | -62.12K |
Operating Income | -34.27M | -35.33M | -36.32M | -39.37M | -39.71M | -43.72M | -43.05M | -51.46M | -48.22M | -42.62M | -41.67M | -29.17M | -28.86M | -26.87M | -21.44M | -19.14M | -16.09M | -13.92M |
Interest Income | 1.88M | 2.22M | 2.51M | 2.69M | 2.77M | 2.84M | 2.9M | 3.07M | 2.34M | 1.66M | 935.33K | 82.12K | 83.33K | 9.39K | 4.35K | 3.38K | 3.23K | 9.24K |
Pretax Income | -37.77M | -37.53M | -38.48M | -41.42M | -41.55M | -45.29M | -44.35M | -52.59M | -49.16M | -43.24M | -42.05M | -29.24M | -28.77M | -26.86M | -21.43M | -19.14M | -16.09M | -13.91M |
Net Income | -36.6M | -35.5M | -37.61M | -40.56M | -40.68M | -43.88M | -42.94M | -51.18M | -47.76M | -42.04M | -40.85M | -28.04M | -27.57M | -22.34M | -16.92M | -14.63M | -11.57M | -13.91M |
Selling & General & Admin | 12.89M | 13.64M | 13.74M | 13.84M | 14.53M | 15.07M | 15.27M | 15.01M | 13.86M | 12.5M | 12.24M | 12.51M | 12.86M | 11.87M | 10.18M | 8.79M | 7.36M | 6.54M |
Research & Development | 21.38M | 21.69M | 22.57M | 25.5M | 25.15M | 28.62M | 27.76M | 36.45M | 34.36M | 30.11M | 29.43M | 16.67M | 16M | 15M | 11.25M | 10.34M | 8.72M | 7.37M |
Other Expenses | -16K | -17K | -17K | -1K | -1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 34.25M | 35.31M | 36.29M | 39.34M | 39.68M | 43.69M | 43.03M | 51.46M | 48.22M | 42.62M | 41.67M | 29.17M | 28.86M | 26.87M | 21.44M | 19.14M | 16.09M | 13.92M |
Interest Expense | 1.1M | 4.43M | 4.67M | 4.75M | 4.61M | 4.41M | 4.21M | 4.28M | 3.36M | 2.36M | 1.4M | 145.25K | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | -14.4K | -28.81K | -28.81K | -28.81K | -14.4K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 26.65M | 35.33M | 36.32M | 39.37M | 39.71M | 43.72M | 43.05M | 51.46M | 48.22M | 42.62M | 41.67M | 29.17M | 28.86M | 26.87M | 21.44M | 19.14M | 16.09M | 13.92M |
Income Tax Expense | -1.17M | -2.04M | -869K | -869K | -873.73K | -1.41M | -1.41M | -214.89K | -210.16K | -3.15K | -5.7K | -1.2M | -1.26M | -4.58M | -4.58M | -4.58M | -4.48M | 42.59K |
Shares Outstanding (Basic) | 45.9M | 40.52M | 36.45M | 36.81M | 36.69M | 34.82M | 31.67M | 30.91M | 30.8M | 30.43M | 28.77M | 28.46M | 28.45M | 26.16M | 28.43M | 28.43M | 23.16M | 22.26M |
Shares Outstanding (Diluted) | 45.9M | 40.52M | 36.45M | 36.81M | 36.69M | 34.82M | 31.67M | 30.91M | 30.8M | 30.43M | 28.77M | 28.46M | 28.45M | 26.16M | 28.43M | 28.43M | 23.16M | 22.26M |
EPS (Basic) | -0.93 | -0.95 | -1.04 | -1.16 | -1.22 | -1.36 | -1.38 | -1.79 | -1.7 | -1.53 | -1.53 | -1 | -0.98 | -0.81 | -0.63 | -0.67 | -0.64 | -0.8 |
EPS (Diluted) | -0.93 | -0.95 | -1.04 | -1.16 | -1.22 | -1.36 | -1.38 | -1.79 | -1.7 | -1.53 | -1.53 | -1 | -0.98 | -0.81 | -0.63 | -0.67 | -0.64 | -0.8 |
EBITDA | -32.68M | -33.05M | -33.75M | -36.61M | -36.88M | -40.76M | -39.97M | -49.07M | -46.48M | -41.63M | -41.42M | -28.93M | -28.71M | -26.8M | -21.43M | -19.14M | -16.08M | -13.91M |
EBIT | -25.1M | -33.11M | -33.81M | -36.67M | -36.94M | -40.88M | -40.14M | -48.3M | -45.55M | -40.62M | -40.4M | -28.84M | -28.78M | -26.86M | -21.44M | -19.14M | -16.09M | -13.92M |
Depreciation & Amortization | 35.72K | 50.84K | 59.79K | 59.07K | 58.34K | 117.88K | 177.84K | 175.01K | 258.28K | 243.88K | 229.85K | 219.23K | 122.82K | 63.84K | 5.36K | 8.31K | 76.08K | 78.72K |